The approval for Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF) supported by data from four ongoing phase 3 trials. Biktarvy combines bictegravir, an integrase strand transfer inhibitor, with
The trial, dubbed IMmotion151, met its co-primary endpoint of progression-free survival (PFS) in patients whose metastatic renal cell carcinoma (mRCC) expressed the PD-L1 protein. In the study, the
During the mid-20th century, multiple chemical compounds with antibacterial properties were analyzed, of which few have been used for development into drugs. By using advanced science and technology, scientists
Feraccru is a stable, non-salt and formulation of ferric iron, which includes differentiated mechanism of action compared to salt-based oral iron therapies. The phase III trial with a primary
PFS is one of the two co-primary endpoints of the trial, dubbed CheckMate -227. Overall survival (OS) is the other endpoint. The phase 3 trial had assessed the
Fremanezumab is an anti-calcitonin gene-related peptide (CGRP) antibody, which is intended to be given as a quarterly or monthly injection. The CGRP ligand is known to be a
Leukine is an immuno-stimulant that advances the growth and activation of a wide range of white blood cells, which activate the body's immune response to battle infections. PTx
The new company, named as Theramex, will manufacture products focused on women and their health. Theramex includes Teva’s formerly-owned women’s health product portfolio across contraception, fertility, menopause and
The technology will help in repairing a human blood vessel, as well as shows the development of new capillaries from a single vessel in response to proper biochemical
The acquisition would improve Seattle Genetics' late-stage clinical pipeline with Tucatinib, an orally available and highly selective tyrosine kinase inhibitor (TKI) for patients with HER2-positive metastatic breast cancer As per the terms
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.